These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3828514)

  • 1. [Effect of the hexapeptide dalargin on ornithine decarboxylase activity in the duodenal mucosa of rats in experimental duodenal ulcer].
    Iarygin KN; Shitin AG; Polonskiĭ VM; Vinogradov VA
    Biull Eksp Biol Med; 1987 Mar; 103(3):319-21. PubMed ID: 3828514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of the peripheral administration of dalargin on ornithine decarboxylase activity in the duodenal mucosa of rats with experimental duodenal ulcers].
    Iarygin KN; Shitin AG; Polonskiĭ VM; Moskovkin GN
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):76-8. PubMed ID: 3801143
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-ulcer action and peripheral opioid activity of the products of dalargin degradation].
    Polonskiĭ VM; Korobov NV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):83-6. PubMed ID: 3026418
    [No Abstract]   [Full Text] [Related]  

  • 4. [The site (central or peripheral) of the anti-ulcer action of dalargin, a synthetic analog of endogenous opioids in an experimental model of cysteamine-induced duodenal ulcer in rats].
    Polonskiĭ VM; Iarygin KN; Krivosheev OG; Moskovkin GN; Vinogradov VA
    Biull Eksp Biol Med; 1987 Apr; 103(4):433-4. PubMed ID: 3032303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of hexapeptide dalargine used in the treatment of duodenal ulcer].
    Smagin VG; Vinogradov VA; Bulgakov SA; Polonskiĭ VM; Bespalova ZhD
    Ter Arkh; 1984; 56(11):49-52. PubMed ID: 6395429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of a dalargin aerosol in treating the exacerbations of uncomplicated duodenal peptic ulcer].
    Buglak NP; Bogdanov NN; Vinogradov VA; Titov MI
    Vopr Kurortol Fizioter Lech Fiz Kult; 1988; (4):19-25. PubMed ID: 3195111
    [No Abstract]   [Full Text] [Related]  

  • 7. [Receptor characteristics of the duodenal mucosa in peptic ulcer: a new approach to the individual selection of the therapy].
    Pavlov SA; Vinogradov VA; Iarygin KN; Shugurov VA; Bogdanov AN
    Ter Arkh; 1989; 61(2):24-7. PubMed ID: 2543094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of thymalin, dalargin and "Mucosalin" on the course of an experimental duodenal ulcer].
    Lukash NV; Polishchuk TF
    Lik Sprava; 1995; (1-2):53-5. PubMed ID: 7483545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Gastrointestinal endocrine cells during the treatment of duodenal ulcer patients with the new peptide preparation dalargin].
    Zverkov IV; Arndt IP; Shcherbakova NV; Smagin VG
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):72-4. PubMed ID: 2879547
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dalargin--a peptide preparation with cytoprotective action].
    Titov MI; Vinogradov VA; Bespalova ZhD
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1985; 8(2):72-6. PubMed ID: 2998416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment of the endocrine status of peptic ulcer patients being treated with dalargin].
    Bulgakov SA; Bogdanov AN; Ovtrakht N; Pavlov SA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):70-1. PubMed ID: 3801141
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of dalargin on repair capacity of gastroduodenal mucosa in patients with duodenal ulcer].
    Timoshin SS; Alekseenko SA; Shtuka AA
    Klin Med (Mosk); 1991 Mar; 69(3):75-7. PubMed ID: 2067344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gastrin, gamma-endorphin and somatostatin cells of the stomach and duodenum in patients with duodenal ulcer treated with dalargin].
    Zverkov IV; Vinogradov VA; Bulgakov SA; Smagin VG; Shcherbakova NV
    Ter Arkh; 1987; 59(2):48-53. PubMed ID: 2437665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of peptic ulcer hemorrhage with leucine enkephalin analog dalargin].
    Georgadze AK; Fomin VB; Bulgakov SA; Fedenko VV
    Khirurgiia (Mosk); 1990 Mar; (3):39-43. PubMed ID: 2193190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dalargin--the first enkephalin analog, used in gastroenterology].
    Vinogradov VA; Polonskiĭ VM
    Ter Arkh; 1988; 60(8):147-53. PubMed ID: 3067406
    [No Abstract]   [Full Text] [Related]  

  • 16. [The synthetic peptide preparation dalargin in the treatment of peptic ulcer].
    Smagin VG; Vinogradov VA; Bulgakov SA; Propisnova EP; Titov MI
    Ter Arkh; 1987; 59(2):44-8. PubMed ID: 3554590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of cysteamine-induced duodenal ulcer with Cochinchina momordica seed extract through inhibiting cytoplasmic phospholipase A2/5-lipoxygenase and activating γ-glutamylcysteine synthetase.
    Choi KS; Kim EH; Hong H; Ock CY; Lee JS; Kim JH; Hahm KB
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():13-22. PubMed ID: 22486866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dalargin--the most active synthetic analog of endogenous opioids for treating peptic ulcer (the results of a 5-year search)].
    Vinogradov VA; Polonskiĭ VM
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):62-3. PubMed ID: 3801137
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of andrographolide on cysteamine-induced duodenal ulcer in rats.
    Panneerselvam S; Arumugam G; Karthikeyan NS
    Nat Prod Res; 2011 Sep; 25(16):1560-4. PubMed ID: 21848489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetics of dalargin].
    Kalenikova EI; Dmitrieva OF; Korobov NV; Zhukovskiĭ SV; Tishchenko VA
    Vopr Med Khim; 1988; 34(1):75-83. PubMed ID: 3369130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.